Welcome
Rebecca Wood
Chief Executive
Welcome
Alzheimer’s Research UK
Alzheimer’s Research UK
• UK’s leading dementia research charity. Second only to
Medical Research Council for research funding
• We have over £20m invested over 140 projects
Royal Society
Parkinson's UK
ESRC
EPSRC
Alzheimer's Society
BBSRC
DoH/NIHR
Wellcome Trust
Alzheimer's Research UK
MRC
0
50
100
150
200
250
Why our work matters
80
70
60
50
40
30
Age 40 - 55
Year
20
40
20
30
20
20
Age 65 +
20
10
20
00
Population (Millions)
• Dementia is the great medical challenge of our time
• Over 820,000 people affected
• Rapid progress, but still too much we don’t know
• Funding remains far behind other diseases
• Population ageing and economic impact
Our research
• Dementia is not inevitable - Research can beat it
• Diagnosis, prevention, treatment and cure
• New strategy
Research progress
• UK research is amongst best in world
• Current drugs, Genetic understanding, Detection
• Funds and attention improving – PM Challenge
Dementia Challenge
Improving Research
Double research funding to £66m by 2015
One year review
• £22 million - 21 new projects through the National Institute for
Health Research (NIHR)
• £4.5m from the Medical Research Council (MRC) to evaluate
existing drugs and potential benefits for people with dementia
• Additional support from MRC for Brain Banking + renewed
commitments from Alzheimer’s Research UK and Alzheimer’s
Society
• Push to increase participation in research through DeNDRoN
• ESRC planning grant of up to £13m; impressed by the quality of
the work
G8
• Prime minister plans to engage G8 on research,
sharing leadership.
• Research Champions are being consulted about key
areas. ARUK is keen to address data exclusivity.
Evington Catalyst
• This group set up by Jan Hall to engage business
leaders and considering the global picture.
Future priorities
• Monitor progress on dementia challenge
• All parties commit investment to dementia research
‘Manifestos 2015’ and new strategy for post-2015
• Increase engagement in dementia research – public, carers
and patients
• New treatments – encourage collaboration in pharma,
academia
Fighting back
Be the difference
• Research needs you!
• Support studies
• Clinical trials - help develop
next generation of drugs
• Share your experiences of care
or accessing services
DeNDRoN
NeuroDem
SDCRN
NICRN (Dementia)
Thank you
Questions
www.alzheimersresearchuk.org